![]() |
Volumn 62, Issue 6, 2015, Pages 814-815
|
DOOR/RADAR: A Gateway into the Unknown?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ETHAMBUTOL;
ISONIAZID;
MOXIFLOXACIN;
RIFAPENTINE;
ANTIINFECTIVE AGENT;
ALTERNATIVE HYPOTHESIS;
ANTIBIOTIC RESISTANCE;
CLINICAL TRIAL (TOPIC);
DESIRABILITY OF OUTCOME RANKING;
HEALTH CARE;
HUMAN;
INTENTION TO TREAT ANALYSIS;
LETTER;
PRIORITY JOURNAL;
PROBABILITY;
RESPONSE ADJUSTED FOR DURATION OF ANTIBIOTIC RISK;
SAMPLE SIZE;
TREATMENT DURATION;
TREATMENT OUTCOME;
TUBERCULOSIS;
METHODOLOGY;
ANTI-BACTERIAL AGENTS;
CLINICAL TRIALS AS TOPIC;
DRUG RESISTANCE, BACTERIAL;
HUMANS;
RESEARCH DESIGN;
|
EID: 84960078503
PISSN: 10584838
EISSN: 15376591
Source Type: Journal
DOI: 10.1093/cid/civ1002 Document Type: Letter |
Times cited : (24)
|
References (4)
|